Can-Fite BioPharma Ltd. (CANF)

NYSEAMERICAN: CANF · IEX Real-Time Price · USD

2.020

+0.060 (3.06%)

At close: Apr 18, 2024, 9:40 AM

1.970

-0.050 (-2.48%)

After-hours: Apr 18, 2024, 6:30 PM EDT

Can-Fite BioPharma Cash Flow Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Net Income	-7.63	-10.17	-12.62	-14.44	-12.63	-6.57	-4.11	8.14	6.4	6.65	Upgrade
Depreciation & Amortization	0.11	0.07	0.07	0.02	0.01	0.01	0.02	0.02	0.02	0.01	Upgrade
Share-Based Compensation	0.26	0.26	0.47	0.36	0.39	0.54	0.19	0.31	0.11	0.22	Upgrade
Other Operating Activities	-1.18	-0.96	2.22	2	1.14	1.87	-5.07	-17.18	-11.34	-14.59	Upgrade
Operating Cash Flow	-8.44	-10.8	-9.86	-12.06	-11.08	-4.16	-8.97	-8.71	-4.82	-7.7	Upgrade
Capital Expenditures	-0	-0.01	-0.01	-0.03	-0	-0.03	-0.01	-0.01	-0.04	-0.01	Upgrade
Acquisitions	0	0	0	0	0	0	-0.02	0	0	0	Upgrade
Change in Investments	0.5	9.51	-14.5	0	0	0	0	0	0	0	Upgrade
Investing Cash Flow	0.5	9.5	-14.51	-0.03	-0	-0.03	-0.03	-0.01	-0.04	-0.01	Upgrade
Share Issuance / Repurchase	9.14	0	20.46	17.68	10.17	4.39	4.47	0	12.51	12.06	Upgrade
Financing Cash Flow	9.14	0	20.46	17.68	10.17	4.39	4.47	0	12.51	12.06	Upgrade
Exchange Rate Effect	0.1	-0.11	0.03	-0.02	0	-0.09	-0.08	-0.08	-0.01	-0.21	Upgrade
Net Cash Flow	1.3	-1.41	-3.88	5.57	-0.92	0.11	-4.61	-8.81	7.64	4.14	Upgrade
Free Cash Flow	-8.44	-10.81	-9.87	-12.09	-11.09	-4.19	-8.98	-8.72	-4.86	-7.71	Upgrade
Free Cash Flow Margin	-1136.20%	-1334.57%	-1156.98%	-1584.40%	-545.62%	-109.63%	-1138.02%	-5287.27%	-2998.15%	-	Upgrade
Free Cash Flow Per Share	-1.98	-3.98	-5.35	-10.12	-38.72	-32.30	-82.82	-94.58	-68.36	-147.37	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).